GET-VIRTUAL: GEnetic Counseling Through Virtual Visits in Parkinson's Disease

Sponsor
University of Pennsylvania (Other)
Overall Status
Recruiting
CT.gov ID
NCT04527146
Collaborator
(none)
320
1
4
35
9.2

Study Details

Study Description

Brief Summary

The research study is being conducted to compare methods of virtual genetic counseling for people with Parkinson's disease.

Condition or Disease Intervention/Treatment Phase
  • Other: IMAGINE-PD
  • Other: Virtual genetic counseling
  • Other: Telephone genetic counseling
N/A

Detailed Description

This research will evaluate different virtual methods of pre-test genetic counseling and post-test genetic results disclosure in people with Parkinson's disease. Participants will be randomized to receive different methods of genetic counseling using web-based, telephone, or telehealth methods. In both pre- and post-test counseling phases, remote genetic counseling methods will be compared to demonstrate equivalence. The primary outcomes will be equivalence on genetics knowledge and outcomes scales, and the revised impact of events scale. The purpose is to develop effective and scalable approaches to genetic counseling. This work is crucial for patient safety and will improve access to care through novel genetic counseling approaches.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
320 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
Enrolled participants will be randomized into one of 4 groups based on pre- and post-genetic test counseling: (1)IMAGINE-PD/Virtual, (2)IMAGINE-PD/Telephone, (3)Virtual/Virtual, and (4)Virtual/Telephone.Enrolled participants will be randomized into one of 4 groups based on pre- and post-genetic test counseling: (1)IMAGINE-PD/Virtual, (2)IMAGINE-PD/Telephone, (3)Virtual/Virtual, and (4)Virtual/Telephone.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
GEnetic Counseling Through VIRTUAL Visits in Parkinson's Disease
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: IMAGINE-PD/Virtual

Pre-test genetic counseling through the Interactive Multimedia Approach to Genetic counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) website. Genetic results disclosure via virtual visit with a genetic counselor.

Other: IMAGINE-PD
The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail.

Other: Virtual genetic counseling
The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the PennChart/EPIC electronic medical record dashboard.

Experimental: IMAGINE-PD/Telephone

Pre-test genetic counseling through the Interactive Multimedia Approach to Genetic counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) website. Genetic results disclosure via telephone with a genetic counselor.

Other: IMAGINE-PD
The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail.

Other: Telephone genetic counseling
The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.

Experimental: Virtual/Telephone

Pre-test genetic counseling virtual visit with a genetic counselor. Genetic results disclosure via telephone with a genetic counselor.

Other: Virtual genetic counseling
The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the PennChart/EPIC electronic medical record dashboard.

Other: Telephone genetic counseling
The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.

Active Comparator: Virtual/Virtual

Pre-test genetic counseling and genetic results disclosure via virtual visit with a genetic counselor.

Other: Virtual genetic counseling
The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the PennChart/EPIC electronic medical record dashboard.

Outcome Measures

Primary Outcome Measures

  1. Knowledge [4 weeks after pre-testing counseling]

    Genetics Knowledge Scale (24-question scale, score range 0-24, higher scores mean greater knowledge)

  2. Genetic Counseling Satisfaction [Immediately after disclosure counseling]

    Genetic Counseling Satisfaction Scale (GCSS) (6-item scale, score range 6-30, higher scores mean greater satisfaction)

  3. Impact [3 months after genetic results disclosure]

    Revised Impact of Events Scale (22-item, score range 0-88, higher scores mean greater event-related distress)

Secondary Outcome Measures

  1. Genetic Counseling Outcomes [6 months after genetic counseling]

    Genetic Counseling Outcomes Scale (GCOS, 24-item scale)

  2. Depression [Immediately after results disclosure and 6 months after counseling]

    Geriatric Depression Scale (GDS, 15-item score range 0-15, higher means greater depression)

  3. Anxiety [Immediately after results disclosure and 6 months after counseling]

    State-Trait Anxiety Index (STAI, 20-item, max score 80, higher means greater anxiety)

  4. Quality of life in Parkinson's disease [Immediately after results disclosure and 6 months after counseling]

    Parkinsons disease quality of life 39 scale (PDQ39)

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Provision of signed and dated informed consent form

  • Stated willingness to have clinical confirmation genetic testing, and comply with all study procedures and availability for the duration of the study

  • Male or female, over the age of 21.

  • English Speaking

Exclusion Criteria:
  • Prior genetic counseling and/or clinical testing specifically for Parkinson's disease

  • MoCA < 21, or a prior diagnosis of dementia during the screening phase

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Parkinsons Disease and Movement Disorders Center Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

  • Principal Investigator: Thomas F Tropea, DO, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thomas Tropea, DO, Assistant Professor, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT04527146
Other Study ID Numbers:
  • 843748
  • PCPM
First Posted:
Aug 26, 2020
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2022